跳至主要内容
临床试验/NCT04181580
NCT04181580已完成不适用

Explorative, Monocentric, Feasibility Study Focusing on Fit of Innovative, Made-to-measure Compression Garments in Healthy Subjects

BSN Medical GmbH1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2019年11月28日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
36
试验地点
1
主要终点
Evaluation of the fit of the investigational device

研究概览

简要总结

Fit of made-to-measure compression garments in healthy subjects will be tested on one day, simulating daily activities.

详细描述

Lower and upper extremities of 36 health subjects will be measured be trained experts to collect measures for made-to-measure compression garments.

Fit of made-to-measure compression garments, which are not on the market yet, among healthy subjects will be tested on one day, simulating daily activities. Fit will be assessed directly after donning and after a wearing period of maximum 7 hours at the study site by trained experts. Healthy subjects will give back study products at the end of the wearing period. AEs will be documented throughout the study.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Men, women or diverse
  • •Full legal competence
  • •Age between 18 and 70 years
  • •Capability to understand the subject information and to provide conscious informed consent
  • •All female or diverse subjects of childbearing potential must either be surgically sterile (hysterectomy or tubal ligation) or agree to use a reliable method of contraception with a Pearl-Index of less than 1% per year when used consistently and correctly such as implants, injectables, combined oral contraceptives, some intra uterine devices (IUDs), sexual abstinence or vasectomized partner for at least 4 weeks
  • •Willingness to conduct a urine pregnancy test for all females or potentially childbearing diverse subjects
  • •Capability and willingness to follow protocol requirements
  • •Signed informed consent for study participation and data protection regulations
  • •Body mass index (BMI) >23 kg/m² and ≤ 40 kg/m²

排除标准

  • •Circumference of the largest circumference of the upper leg >80 cm (measured in the upright position)
  • •Shape distortions
  • •Diagnosed lymphedema of the upper and/or lower extremities
  • •Diagnosed lipedema of upper and/or lower extremities
  • •Diagnosed indication for therapy with flat-knitted compression garments
  • •Alcohol abuse as reported by subject and/ or suspected by investigator
  • •Drug abuse as reported by subject and/ or suspected by investigator
  • •Allergy or sensitivity to one or more components of the investigational devices, as far as reported by the subject
  • •Circumference of the largest circumference of the upper leg >80 cm (measured in the upright position)
  • •Shape distortions
  • •Diagnosed lymphedema of the upper and/or lower extremities
  • •Diagnosed lipedema of upper and/or lower extremities
  • •Diagnosed indication for therapy with flat-knitted compression garments
  • •Alcohol abuse as reported by subject and/ or suspected by investigator
  • •Drug abuse as reported by subject and/ or suspected by investigator
  • •Allergy or sensitivity to one or more components of the investigational devices, as far as reported by the subject
  • •Pregnancy or breastfeeding
  • •Diagnosed peripheral arterial disease
  • •Presence of untreated phlebitis, or septic phlebitis
  • •Diagnosed progressed arterial insufficiency including ischemia
  • •Diagnosed congestive heart failure
  • •Diagnosed clinically relevant hypertension
  • •Diagnosed renal insufficiency or kidney failure
  • •Presence of Untreated or progressing skin infection
  • •Presence of large coagulum in the leg vein
  • •Presence of phlegmasia coerulea dolens
  • •Diagnosed Raynaud's disease
  • •Diagnosed gonarthrosis
  • •Diagnosed ankle arthrosis
  • •Diagnosed rheumatoid arthritis
  • •Presence of Exuding dermatoses
  • •Presence of gangrene
  • •Diagnosed malign lymphedema
  • •Diagnosed psoriasis
  • •Diagnosed diabetes mellitus
  • •Diagnosed complex regional pain syndrome (CRPS; Sudeck atrophy)
  • •Diagnosed polyneuropathy
  • •Diagnosed severe impaired skin sensitivity und impaired sensitivity of the extremities, including all sensory malfunctions and diagnosed impaired pain sensitivity
  • •Objections of the investigator to the subject's participation in the trial due to medical reasons or any other reason for which the subject should not participate in the opinion of the investigator
  • •Participation in any clinical investigation with systemic and/or pharmaceutical substances within the last 4 weeks and/or in parallel
  • •Sponsors, manufacturers or CRO staff

研究组 & 干预措施

Fit test of made-to-measure garments

Other

Healthy subjects will test maximum 2 compression garments out of 6 garments under investigation

干预措施: Made-to-measure compression garment (Device)

结局指标

主要结局

Evaluation of the fit of the investigational device

时间窗: One day

Evaluation of the fit of the investigational medical device at the end of a wearing period of approximately 4 - 7 hours by predefined criteria, to be worn by healthy subjects once.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验